USPTO serial 98166215
UTRIM
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- NEAL, KELLY L
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with UTRIM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Winnipeg, MB, CA
Winnipeg, MB, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Adriano Pacifici
Adriano Pacifici INTELLECTUAL PROPERTY CONSULTING, LLC400 POYDRAS STREETSUITE 1400NEW ORLEANS, LA 70130Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Lipid nanoparticles for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing surface chemistry for attachment of any protein, peptide and molecule to bind proteins of interest for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, and metabolic disorders; Biochemical preparations for scientific medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders; Reagents for scientific research and medical research use; Chemical reagents for non-medical purposes; Diagnostic reagents for clinical or medical laboratory use; chemistry reagents for scientific research and medical research use; Reagents comprised of nanoparticles for scientific research and medical research use; Reagents comprised of capsids for scientific research and medical research use; Reagents, namely, lipid nanoparticles, for scientific research and medical research use | ACTIVE | — |
| 005 | Pharmaceutical products, namely, lipid nanoparticles, for treating respiratory diseases; Pharmaceutical preparations for treating respiratory diseases, namely, a lipid-enabled drug for binding to agents of interest in particular viruses, bacteria, free-circulating proteins in the body; Pharmaceutical agents for treating respiratory diseases in the nature of biological blocking agents in the form of lipid nanoparticles that facilitate the binding of viruses, bacteria, protein of interest in biological fluids; Pharmaceutical preparations for the treatment of diseases and disorders, namely, allergies, autoimmune diseases, cancer, cardiovascular diseases, genetic diseases, hematological diseases, infectious diseases, inflammatory diseases, metabolic diseases, neurological diseases, ocular diseases and respiratory diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 21, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 20, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 20, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 20, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 20, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 20, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 20, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 20, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 21, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 20, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 20, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 20, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 20, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 19, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 19, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 19, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 20, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 25, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 25, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 5, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 16, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 13, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 13, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 3, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 28, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 9, 2023 | NWAP | NEW APPLICATION ENTERED | — |